PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Phathom Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$7.01+0.09 (+1.30%)
Close on Oct 19, 2026
- Market cap
- $587.07M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Phathom Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 23, 2026 | Oct 23, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2026 | Sep 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 19, 2026 | Apr 7, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 25, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2025 | Oct 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 3, 2025 | Apr 23, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 16, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Apr 1, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2025 | Mar 6, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 6, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 11, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2024 | Aug 19, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 18, 2024 | Jul 18, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | Jun 14, 2024 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Mar 31, 2024 | Jun 14, 2024 | SEC EDGAR |
| Current report | 8-K | May 23, 2024 | May 24, 2024 | SEC EDGAR |